StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.85+0.41 (+1.49%)

Close on Nov 17, 2026Market cap $4.83BP/E –Yield –

Cogent Biosciences cash

Cash and short-term investments held at the end of each period.

Cogent Biosciences's cash was $792.30M at Jun 30, 2026. For fiscal 2025 it was $900.77M, up 213.8% from the year before. The highest annual figure on record is $900.77M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$900.77M+213.8%
FY2024Dec 31, 2024$287.08M+8.0%
FY2023Dec 31, 2023$265.71M+2.0%
FY2022Dec 31, 2022$260.53M+17.9%
FY2021Dec 31, 2021$220.94M-9.2%
FY2020Dec 31, 2020$243.45M+529.4%
FY2019Dec 31, 2019$38.68M-32.1%
FY2018Dec 31, 2018$56.93M+34.6%
FY2017Dec 31, 2017$42.29M-0.7%
FY2016Dec 31, 2016$42.58M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$792.30M+233.1%
Q1 FY2026Mar 31, 2026$866.38M+252.7%
Q4 FY2025Dec 31, 2025$900.77M+213.8%
Q3 FY2025Sep 30, 2025$390.89M+16.5%
Q2 FY2025Jun 30, 2025$237.85M-34.5%
Q1 FY2025Mar 31, 2025$245.66M-43.6%
Q4 FY2024Dec 31, 2024$287.08M+8.0%
Q3 FY2024Sep 30, 2024$335.52M+20.2%
Q2 FY2024Jun 30, 2024$363.22M+10.3%
Q1 FY2024Mar 31, 2024$435.74M+96.7%
Q4 FY2023Dec 31, 2023$265.71M+2.0%
Q3 FY2023Sep 30, 2023$279.04M-3.9%
Q2 FY2023Jun 30, 2023$329.40M+0.8%
Q1 FY2023Mar 31, 2023$221.52M+15.2%
Q4 FY2022Dec 31, 2022$260.53M+17.9%
Q3 FY2022Sep 30, 2022$290.35M+42.2%
Q2 FY2022Jun 30, 2022$326.82M+49.0%
Q1 FY2022Mar 31, 2022$192.30M-17.1%
Q4 FY2021Dec 31, 2021$220.94M-9.2%
Q3 FY2021Sep 30, 2021$204.14M+56.2%
Q2 FY2021Jun 30, 2021$219.36M+870.7%
Q1 FY2021Mar 31, 2021$231.99M+651.8%
Q4 FY2020Dec 31, 2020$243.45M+529.4%
Q3 FY2020Sep 30, 2020$130.68M+177.2%
Q2 FY2020Jun 30, 2020$22.60M-60.4%
Q1 FY2020Mar 31, 2020$30.86M-48.9%
Q4 FY2019Dec 31, 2019$38.68M-32.1%
Q3 FY2019Sep 30, 2019$47.14M-6.8%
Q2 FY2019Jun 30, 2019$57.12M+18.9%
Q1 FY2019Mar 31, 2019$60.37M+79.1%
Q4 FY2018Dec 31, 2018$56.93M+34.6%
Q3 FY2018Sep 30, 2018$50.55M+58.2%
Q2 FY2018Jun 30, 2018$48.04M+47.8%
Q1 FY2018Mar 31, 2018$33.71M-2.3%
Q4 FY2017Dec 31, 2017$42.29M-0.7%
Q3 FY2017Sep 30, 2017$31.95M–
Q2 FY2017Jun 30, 2017$32.51M–
Q1 FY2017Mar 31, 2017$34.49M–
Q4 FY2016Dec 31, 2016$42.58M–

More Cogent Biosciences figures

See a number that looks wrong?